rfk glp-1 Jr. Could Shake up the Weight Loss Industry in the Age of Ozempic RFK Jr., Dr. Oz set

The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).

Think again

Pfizers GLP-1 weight management treatment Xianweiying, is reportedly available for pre-order in China in the wake of intensifying competition with rivals in a market analysis expected to be...

This mini review explores the increasing prevalence of obesity in type 1 diabetes (T1D) and the challenges patients face in achieving optimal glycemic contro...

[Extended 6-8H Cooling & Thermal Insulation]: Constructed with a premium PU leather shell, high-density EVA, and upgraded aluminum foillining, our GLP-1 cooler case provides a rugged thermal barrier

GLP-1s are becoming a bigger part of weight management